Source:http://linkedlifedata.com/resource/pubmed/id/19049429
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
24
|
pubmed:dateCreated |
2008-12-24
|
pubmed:abstractText |
Imaging of programmed cell death (apoptosis) is important in the assessment of therapeutic response in oncology and for diagnosis in cardiac and neurodegenerative disorders. The executioner caspases 3 and 7 ultimately effect cellular death, thus providing selective molecular targets for in vivo quantification of apoptosis. To realize this potential, we aimed to develop 18F-labeled isatin sulfonamides with high metabolic stability and moderate lipophilicity while retaining selectivity and affinity for caspase 3/7. A small library of isatins modified with fluorinated aromatic groups and heterocycles was synthesized. A lead compound incorporating 2'-fluoroethyl-1,2,3-triazole was identified with subnanomolar affinity for caspase 3. "Click labeling" provided the 18F-labeled tracer in 65 +/- 6% decay-corrected radiochemical yield from 2-[18F]fluoroethylazide. The compound showed high stability in vivo with rapid uptake and elimination in healthy tissues and tumor. The novel 18F-labeled isatin is a candidate radiotracer for further preclinical evaluation for imaging of apoptosis.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-fluoroethylazide,
http://linkedlifedata.com/resource/pubmed/chemical/Azides,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 7,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Isatin,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1520-4804
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
25
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8057-67
|
pubmed:meshHeading |
pubmed-meshheading:19049429-Animals,
pubmed-meshheading:19049429-Azides,
pubmed-meshheading:19049429-Caspase 3,
pubmed-meshheading:19049429-Caspase 7,
pubmed-meshheading:19049429-Chemistry, Pharmaceutical,
pubmed-meshheading:19049429-Drug Design,
pubmed-meshheading:19049429-Enzyme Activation,
pubmed-meshheading:19049429-Enzyme Inhibitors,
pubmed-meshheading:19049429-Fluorine Radioisotopes,
pubmed-meshheading:19049429-Humans,
pubmed-meshheading:19049429-Isatin,
pubmed-meshheading:19049429-Male,
pubmed-meshheading:19049429-Mice,
pubmed-meshheading:19049429-Neoplasm Transplantation,
pubmed-meshheading:19049429-Neoplasms,
pubmed-meshheading:19049429-Radiopharmaceuticals
|
pubmed:year |
2008
|
pubmed:articleTitle |
Design, synthesis, and biological characterization of a caspase 3/7 selective isatin labeled with 2-[18F]fluoroethylazide.
|
pubmed:affiliation |
Molecular Therapy Group, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|